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Research suggests that elevated serum concentrations of 25-hydroxyvitamin D (25OHD) 
are associated with slowing the development of many age-related chronic diseases. Recent 
reports also show a positive relationship between 25OHD and muscle synthesis, strength, power 
and decreased body fat in elderly individuals. However, these findings have not been 
consistently reported in younger, healthy populations.  PURPOSE: To investigate the 
relationship between 25OHD levels, body composition, measures of aerobic fitness and muscular 
strength and power in a young, physically active population.  METHODS: Thirty-nine active 
subjects (20 males, 19 females; 23 ± 0.7 years old) reported to the lab six times for testing.  
Blood was drawn and 25OHD concentrations were determined using an enzyme-linked 
immunosorbent assay (ELISA). Primary outcomes included: body composition (dual-energy x-
ray absorptiometry, DXA); resting metabolic rate; maximal oxygen uptake (VO2max); power 
output (Wingate); and strength (eight repetition maximum of bench press, upright row and leg 
extension and flexion). Primary analysis included all participants, and sub-group analyses on 
those individuals considered to have sub-optimal serum 25OHD (< 35 ng/mL); LOW (n = 20, 
25.97 ± 1.97 ng/mL) and adequate levels of 25OHD (< 35 ng/mL) HIGH (n =19, 44.15 ± 2.17 
ng/mL).  RESULTS: Half of the subjects (n = 20) exhibited less than optimal 25OHD status, 
due in part to lack of dietary intake.  HIGH males had significantly higher VO2max values when 
compared to LOW males (p < 0.01). CONCLUSION:  A high percentage of college-aged male 
and female individuals may not be consuming enough vitamin D and aerobic fitness may also be 
linked to vitamin D status. 
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CHAPTER 1 – INTRODUCTION 
 
Vitamin D has garnered a significant amount of attention for its potential to improve 
overall health and quality of life in humans.  Low vitamin D status has been linked to obesity, 
cardiovascular disease, type 2 diabetes, cancer and other diseases common in our society today.  
However, more research is needed in order to fully understand the benefits of improving vitamin 
D status and its cellular mechanisms of action. 
One of the most applicable newly discovered benefits of vitamin D supplementation is its 
role in muscle protein synthesis (1).  Type I muscle fibers, known also as slow-twitch fibers, 
have increased oxidative capacity and low glycolytic activity and are resistant to fatigue (2).  
Type IIa fibers have both high oxidative and glycolytic activity, while type IIb fibers have high 
glycolytic and low oxidative capacity and wear out quickly (2).  Different muscles have varying 
quantities of fiber types based on the type of training and genetics.  For example, those who run 
marathons have more type I fiber content overall, while weight-lifters have more type II fibers 
(2).  Originally, studies involving vitamin D and muscle growth and composition were conducted 
in elderly populations (3, 4).  Muscle biopsies of elderly patients with vitamin D deficiency 
indicated atrophy of type II muscle fibers, which are those recruited first to help prevent falls (5). 
Current research found that supplementation with vitamin D increased functional muscle tissue 
in elderly patients (4).  Specifically, improved lower extremity function, as assessed by 8 foot 
walk tests and sit-to-stand tests, has been associated with higher 25-hydroxyvitamin D (25OHD) 
levels in both active and inactive subjects over the age of 60 (4).  Supplementation studies 
examining the changes in muscle fiber morphology are few in number, but several have shown 
an improvement in overall muscle composition. Sorensen, et al. showed that 3-6 months of 
supplementation with calcium and vitamin D (in the form of 25OHD), led to an increase in 
cross-sectional area of type IIa fibers (6).  However, this study provided 25OHD 
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supplementation combined with calcium, and did not primarily focus on muscle morphology.  
More recently, a significant increase in the number and diameter of type II fibers, along with a 
concurrent increase in strength were observed after several years of supplementation in elderly 
subjects (7).  The most important finding in these studies was that the improvement in muscle 
composition translated into an increase in functional capabilities such as strength, fall prevention 
and ability to perform activities of daily living (8).   
Not only does vitamin D supplementation have the potential to increase muscle protein 
synthesis, but there may be concomitant reductions in adiposity as well (9).  A cell culture 
project determined that incubation of 3T3-L1 preadipocytes with 1,25(OH)2D prevented 
differentiation into adipocytes in a dose-dependent manner (10).  A complete understanding of 
the role of vitamin D in adipocyte regulation has no defined direction even though multiple 
possible routes show a potential understanding of the decrease in adiposity.  While the 
mechanisms have yet to be completely elucidated, it is apparent that improved vitamin D status 
is correlated with a more favorable body composition (11). 
With the increased interest in non-osseous functions of vitamin D, many researchers have 
become concerned with the vitamin D status of athletes (12).  Since the discovery of the 
physiological changes that take place in the elderly after increasing circulating levels of 25OHD, 
research has been done investigating the benefits of increasing the status in these physically 
active individuals.  While no conclusive results have been reported concerning the changes in 
body composition or muscle physiology in a younger, physically active population, one major 
determination has become apparent: a significant number of athletes – regardless of sport or 
season – have insufficient or deficient vitamin D levels (12).  Therefore, it is important to 
investigate both the incidence of insufficiency of vitamin D in a healthy, physically active 
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population, as well as the potential relationships between serum 25OHD and measures of fitness 
and athletic performance. 
In summary, longitudinal studies indicate that an increase in muscle tissue is 
accompanied by a decrease in fat mass, and vitamin D status is one of the most robust predictors 
of muscle mass decrease with aging (13).  These findings lead us to ask whether similar results 
will be observed in the general population.  Additionally it is also important to address whether 
improvements in vitamin D status result in an increase in muscle tissue and if these 






CHAPTER 2 – REVIEW OF LITERATURE 
Sources of Vitamin D in the Diet 
 The majority of the world’s population has low levels of vitamin D, with estimates 
reaching as high as 59 percent worldwide.  Additionally, it has been estimated that over 60 
percent of Americans may also be deficient in vitamin D (16, 17).  This phenomenon may be due 
to misinformation about the sources and conversion of vitamin D into a physiologically relevant 
form.  For example, some nutritionists and educators believe that sufficient amounts are ingested 
in a normal healthy diet (1), while others disagree (15). 
Vitamin D is readily available in the American diet, albeit not in large quantities.  It is 
unlikely that the prevalence of vitamin D deficiency and insufficiency would be seen at the 
astronomical rates observed today if it were a standard part of a normal diet.  Vitamin D is even 
less likely to be found in diets in developing countries due to the reduced access to foods 
naturally containing vitamin D, as well as lack of regulation regarding the fortification of foods 
with vitamin D that are present in developed countries (16).  Vitamin D content is highest in fatty 
fish and liver, particularly cod liver (16).  In the United States, most cereals, grains, orange juice 
and dairy products are fortified with vitamin D, in amounts required by the Food and Drug 
Administration (16).  Even with adequate intake through the diet, most individuals have 
insufficient vitamin D levels in the body (17).  Up until late 2010, the Institute of Medicine 
(IOM) Dietary Reference Intakes indicated that the Recommended Dietary Allowance (RDA) of 
vitamin D should be 400 IU per day for healthy adults, with higher values for elderly and youth.  
These values were regarded by nutritionists, researchers, and physicians as severely insufficient 
(16).  The IOM recommendation release in 2010 increased the RDA to 600 IU per day for 
individuals between the ages of one and 71 years old, although this value is still widely debated 
in the research community as inadequate.  As a result, there is an increased likelihood for 
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individuals on a fortified diet to have low levels of vitamin D and recommendations can be made 
as to increasing status applicable to everyone (18).   
Vitamin D Synthesis 
 Vitamin D synthesis takes place in several different steps.  A precursor compound known 
as 7-dehydrocholesterol (7DHC), stored in the skin, is converted to previtamin D3 when photons 
from UVB light come in contact with a particle of 7DHC (17).  Optimal wavelengths for this 
conversion are less than 315 nm (17).  However, these wavelengths typically do not make it 
through the ozone layer to come in contact with the surface of the earth (17).  Different 
wavelengths of light cause different isomers from 7DHC and limits how much previtamin D3 is 
formed (17).  Current estimates range from 12-15% of 7DHC is actually converted to previtamin 
D3, which ultimately determines the amount of vitamin D that is synthesized (17).   
 Once previtamin D3 is made, it is further converted to vitamin D3 with heat (17).  The 
first two conversion steps happen together, since heat accompanies UV radiation.  Vitamin D3 is 
mobilized by binding to the D binding protein (DBP) and enters circulation.  Upon reaching the 
liver, vitamin D3 is converted to its active form of 25-hydroxyvitamin D (25OHD)(17).  25-
hydroxyvitamin D enters circulation and is converted to 1,25-dihydroxyvitamin D (1,25(OH)2D) 
in the kidneys (19).  It is 1,25(OH)2D that is the metabolically active form of vitamin D (17).  
Because of the time course in vitamin D synthesis and metabolism, serum concentration of 
25OHD is widely preferred as the standard for determining vitamin D status, when compared to 
serum 1,25(OH)2D levels (19).   
Vitamin D, Muscle In Elderly/Diseased vs. Athletic Populations  
Even though the benefits of increased strength with vitamin D supplementation were not 
a direct measure in initial studies, more recent research in elderly populations confirms that 
vitamin D supplementation may lead to increased muscle strength (1), or an increase in the force 
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produced by the muscle (20).  Other results have shown that increased levels of 25OHD are 
positively correlated fat free mass (9), including muscle, bone, tissue, and cellular contents (21).  
While results show that there is an increase in muscle tissue, as determined by DXA and biopsies 
and enzymatic activity of tissue samples, it is important to note that this increase is not of clinical 
significance if it is not accompanied by an improvement in strength.  In fact, current studies 
indicate that supplementation with vitamin D, along with strength training activities, in elderly 
subjects not only leads to an increase in muscle tissue but an increase in strength as well (22).   
It is well established that vitamin D plays an integral role in improving bone density and 
calcium absorption (23). Research began by investigating the role of vitamin D and calcium 
supplementation in elderly subjects to prevent osteomalacia, the softening of bone tissue due to 
lack of vitamin D and subsequent absorption of calcium (24).  Because of the increased calcium 
absorption in bones, and with the aid of vitamin D, bone density increased in these patients and 
osteomalacia was reduced (25).   Further investigation indicated that myopathy was significantly 
correlated to the prevalence of osteomalacia and decreased bone density; furthermore, 
supplementation with vitamin D seemed to benefit those suffering from osteomalacia not only by 
increasing bone density but by increasing muscle strength as well (6).   
 Vitamin D research focusing on changes in muscle mass first began when low levels of 
serum 25OHD were correlated with myopathy (26).  The onset of sarcopenia and loss of muscle 
mass and strength is inevitable for every person, regardless of training state or physical ability.  
Sarcopenia is characterized by the loss of type II muscle fibers, those that are predominately 
active in strength generation (27).  While many exercise rehabilitation programs focus on 
resistance training for elderly individuals, the new muscle fibers that develop from this type of 
training are type I fibers, which are more oxidative in nature (27).  Many studies investigating 
increased muscle synthesis, both as an increase in fiber number or an increase in size of existing 
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fibers, and strength in those suffering from sarcopenia note that building muscle strength is 
important in elderly populations to decrease falls risks and maintain functional ability (28).  
Resistance training is the preferred method of training for these individuals for two reasons: first, 
the exercise directly stimulates the target of interest in skeletal muscle instead of a systemic 
effect that would be characteristic of aerobic activities; secondly, because elderly individuals in 
this situation are already prone to falling because of decreased strength, resistance training types 
of activities can be carried out in a more controlled environment in order to decrease this risk 
(22).  The problem with resistance training activities is that while the muscle is being 
resynthesized, it is not being replaced by a metabolic or functional equivalent in terms of fiber 
types.  For example, one intervention study saw increases in both type I and type II fiber cross- 
sectional area after 15 and 30 weeks of training, but the increases in type I fibers were significant 
at both time points.  There was no increase in type II fiber cross-sectional area at 15 weeks, and 
the increase seen at 30 weeks was vastly lower than the increase seen in type I fibers even though 
it was considered statistically significant (29).  Vitamin D supplementation is believed to bring a 
potential solution to this problem.  Several studies have indicated that vitamin D 
supplementation, in conjunction with resistance training activities, increases muscle strength by 
increasing the number of type II fibers (30). 
The advantages of vitamin D supplementation should not be limited to the clinical 
setting.  While studies dating back to the 1940s have correlated vitamin D levels with increases 
in strength performance in athletes (1), this interest has not been maintained until recently.  
Currently, only a few studies have investigated the role of vitamin D in athletes and the 
implications on performance.  Research involving vitamin D supplementation has revealed the 
importance of maintaining bone density, increased muscle synthesis, and its role in increasing 
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immune function in athletes (31), but most have only speculated that increasing vitamin D status 
in these individuals could increase performance and never explicitly explored this hypothesis.   
While all of these benefits stand to increase athletic performance in trained individuals, 
no specific correlations between these phenomena have been drawn to the physiological 
responses that occur during exercise.  A review of the literature indicates a two-fold importance 
of sufficient levels of vitamin D in athletes: first, that deficiency can impede and limit 
performance, and second, that increasing vitamin D levels in non-deficient athletes may improve 
athletic performance (32). Some of the first studies investigating the effects of vitamin D and 
athletic performance were carried out in Germany in the 1950s, when it was determined that 
athletes with increased UV exposure time routinely had increased performance results.  It has 
also been determined recently that athletes who train indoors and during the winter are at 
increased risk for deficient levels and decreased performance (32).  One such study showed that 
German gymnasts had significantly lower serum 25OHD levels, and 37% of participants’ levels 
were in the range for osteomalacia and 45% presenting with symptoms of hypocalcemia.  While 
these levels were not correlated directly with a decrease in performance, the risk associated with 
low levels of calcium, such as softened bone tissue and grand mal seizures (as observed in the 
study) certainly leads to unsafe conditions for athletic performance (32).  Although there are very 
few recent, published studies that have investigated the role of vitamin D status and athletic 
performance, an investigation revealed a direct positive correlation, in females ages 12 to 14 
years, between serum 25OHD levels and muscle power and force using a series of leg strength 
and jumping tests (33).  In conclusion, athletes engaging in both aerobic and resistance types of 
activities may be at risk for vitamin D deficiency-related performance implications, which are 
magnified if they train or perform during winter months when natural UV levels are decreased. 
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The benefits of vitamin D are well established for elderly populations (4).  To date, there 
has been much speculation about the performance-enhancing potential of vitamin D 
supplementation in athletes (12); however, no consistent link has been made between these two 
very polar populations.  As a result, it is possible for clinically healthy individuals engaging in 
recreational activities to benefit from an improvement in vitamin D status.   
Known Molecular Mechanisms of Vitamin D 
Because calcium absorption in bone is so tightly regulated by the amount of vitamin D in 
the body, athletes should be careful to take in the appropriate amount of vitamin D to lower the 
risk of fractures, which could impede on performance and training (31).  The molecular 
mechanism between 25OHD and increased cell synthesis, especially in the muscles, seems to 
indicate that the active form 1,25(OH)2D binds to the vitamin D nuclear receptor.  This complex 
interacts with the retinoic x-receptor (RXR), which binds to vitamin D response elements 
(VDRE), which activate gene sequences that regulate cell growth.  This process is hypothesized 
to regulated protein synthesis in muscle cells, but is not completely understood at this point (31).  
Aside from its role in cell proliferation in the immune system, vitamin D has also been tied to the 
secretion of antimicrobial peptides from cells of the immune system such as monocytes and 
macrophages, which act by degrading the membrane of pathogenic substances (31).  Vitamin D 
is also hypothesized to help regulate the release of both proinflammatory and anti-inflammatory 
cytokines, which are released during exercise, although this mechanism is not known at this 
point (31).   
Vitamin D Status and Fat Mass 
Multiple studies have linked vitamin D status, quantified by both 25OHD and 
1,25(OH)2D levels, to body mass.  Most studies have indicated that higher 25OHD status is 
correlated with lower body mass, although this relationship is not robust and some researchers 
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debate on whether 25OHD or 1,25(OH)2D is the best marker of vitamin D status (19).  The 
consensus in the current literature seems to indicate that 25OHD is the best predictor of overall 
vitamin D status, with a majority of the articles noting a stronger negative relationship between 
body fat and 25OHD than with 1,25(OH)2D because of its regulation of PTH.  However, it is 
important to note that Lagunova, et al, indicated that both 25OHD and 1,25(OH)2D were 
predictors of body mass index (BMI), fat mass, and percent adiposity (34).    
Exploring the relationship between vitamin D status and body composition also has other 
challenges.  Because vitamin D is a fat-soluble vitamin, it is possible that those with increased 
adiposity would have increased stores of vitamin D.  However, this does not appear to be true.  
In fact, obese individuals are one of the most at-risk populations for hypovitaminosis D, or 
deficiency of vitamin D, and the associated symptoms and health risks (35).  This observation is 
due to the bioavailability of circulating 25OHD and the nature of vitamin D metabolism.  One 
study proved this phenomenon quite well, by supplementing both obese and non-obese subjects 
with identical oral doses of vitamin D3 and exposing them to identical amounts of UVB light 24 
hours after ingestion.  The study hypothesis assumed that the obese subjects would have 
increased serum levels of 25OHD due to the increased fat stores for vitamin D, as well as larger 
body surface area able to absorb the UV light.  The results showed the opposite.  The obese 
subjects had significantly lower vitamin D levels despite equal levels of 7DHC, UV exposure 
time, and ingested vitamin D when compared to non-obese counterparts (36).  The article 
summarized, “obesity did not affect the capacity of the skin to produce vitamin D3, but may have 
altered the release of vitamin D3 from the skin into the circulation” (36).  A review of the 
literature concurs with this notion, noting that the increased adiposity between the subcutaneous 
stores of vitamin D and the circulatory system limit the available amount of 25OHD for use by 
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the body, and increased in storage sites for vitamin D leading to a preference for storage rather 
than circulation (34).  
 Although increased obesity is correlated with decreased serum 25OHD levels, there is 
also significant speculation that supplementation with vitamin D could lead to an increased rate 
of lipolysis (37).  While the mechanism has not been completely identified at this point, one 
popular belief involves the role of 1,25(OH)2D and the control of the calcium adipocyte 
signaling pathway.  It was previously believed that 1,25(OH)2D was responsible for increasing 
calcium levels in adipocytes, causing an increase in lipogenesis and a decrease in lipolysis (38).  
This tends to support the notion that increased vitamin D levels would increase adiposity, which 
is not the current belief as 25OHD has been correlated with an increase in lean body mass (39).   
Summary and Specific Aims 
Though the relationships between vitamin D, body composition and athletic performance 
have been established independently in populations of various ages (9, 21, 40), a comprehensive 
study examining all of these factors together has yet to be completed in a young population.  
Vitamin D also provides gains in two significant areas – clinical importance and health benefits 
(41), as well as performance gains (12, 31) – that serve two very contrasting populations of 
individuals.  Accordingly, it the specific aim of this study to investigate the relationship between 
25OHD levels, body composition and resting metabolic rate, measures of aerobic fitness, and 
muscular power and strength in a young, physically active population.  It is hypothesized that 
many of the subjects will have low levels of 25OHD, and that there will be a positive 
relationship between 25OHD and measures of aerobic fitness and strength, as well as an inverse 
relationship between 25OHD and overall adiposity.   
In conclusion, vitamin D is already known to be one of the most necessary supplements 
for optimal health in all individuals (42).  It is exciting to investigate new benefits of a 
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supplement that is already known to support necessary physiological processes, especially 
knowing that most people are clinically deficient, including a large number of physically active 
individuals.  A positive relationship among muscle strength, mass and serum 25OHD is 
somewhat substantiated by the literature (39), indicating potential benefits for athletes by 
improving vitamin D levels.   
 13 
CHAPTER 3 – METHODS 
Study Subjects 
Forty subjects (n = 20 males, n = 20 females; ages 18-40 years) were recruited to 
participate in the study. To be eligible for the study, participants were required to be physically 
active in moderate to vigorous intensity activities for at least 3 days per week and have had 
maintained a consistent body weight for three months prior to the study.  Subjects had no history 
of supplementing with vitamin D outside of what is included in a daily multivitamin (400 IU).  
This project was approved by the Louisiana State University Institutional Review Board. 
Study Design 
Subjects reported to the lab six times.  On the first day, all subjects signed an informed 
consent document, completed physical activity and health assessment questionnaires and height 
and weight were recorded.  Subjects then completed tests to determine resting metabolic rate, 
plasma vitamin D status, body composition, maximal cardiorespiratory fitness (VO2max) and 
anaerobic power, strength and flexibility over the course of five additional visits that took place 
over a 14-day period.  At least 72 hours of rest were included between the anaerobic power, 
VO2max and strength tests to allow for adequate recovery.  Resting metabolic rate and blood 
collection took place on days 5 to 7 of the menstrual cycle for females, as these measurements 
can be influenced by hormone cycles.   
Blood Collection and Analysis 
 During the assessment period, subjects reported to the lab for a single blood draw.  They 
were asked to refrain from strenuous exercise for 24 hours and fasted for 12 hours prior to 
collection.  A registered nurse collected 20 mL blood samples in vacutainers containing no 
additive in the exercise biochemistry lab at Louisiana State University.  Samples were allowed to 
chill for at least one hour at 8-10°C, after which they were centrifuged at 10°C (10 minutes, 1000 
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rcf) and plasma aspirated, aliquoted and stored at -80°C until analysis.  Vitamin D (25OHD) 
status was determined using ELISA (Alpco Diagnostics, Salem, NH) with a BioTek microplate 
reader (BioTek Instruments, Model MQX200, Winooski, Vt., USA). 
Sun Exposure and Dietary Intake 
A week before blood collection, subjects were issued two surveys that accounted for their 
overall endogenous vitamin D production and exogenous dietary intake, which were returned at 
the time of the blood collection.  The first questionnaire was a sun exposure survey to quantify 
the amount of time spent outdoors and in sunlight, since endogenous vitamin D is produced by 
exposure to ultraviolet light.  This method, set forth by Hanwell et al., combines the time spent 
outdoors or in exposure to ultraviolet light into a numerical scale (43).  The second questionnaire 
was a seven day dietary log that was analyzed for dietary 25OHD content using the USDA 
database (44). 
Resting Metabolic Rate 
 Resting metabolic rate (RMR, kcal/day) was assessed via analysis of oxygen 
consumption using a metabolic cart (Moxus Metabolic Systems, Pittsburgh, PA).  Subjects 
arrived at the lab after a 12-hour fast and having refrained from strenuous exercise for 24 hours.  
Subjects were asked to lie in a supine position in a thermoneutral environment while data were 
collected.  The procedure continued until 10 minutes of steady state data was collected, defined 
as ± 5% of the respiratory exchange ratio (45).  RMR was calculated via the modified Weir 
equation (46). 
Body Composition – Dual-energy X-ray Absorptiometry (DXA) 
 Whole-body DXA scans were performed by a trained technician using a General Electric 
Lunar iDXA (General Electric; Milwaukee, WI) and analyzed using enCORE software version 
13.40.  The subject first changed into a hospital gown and removed all metal objects from his or 
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her body.  The subject was centered on the surface of the machine and secured.  The subject was 
instructed to lie completely motionless for the duration of the scan, which lasted 
approximately10 minutes. 
Cardiorespiratory Fitness Testing 
 VO2max was analyzed using a modified Bruce Protocol (47).  Participants were asked to 
refrain from alcohol consumption and vigorous exercise for 24 hours prior to testing.  This 
protocol required participants to walk or run on a treadmill while the speed and incline was 
progressively increased until the subject reached fatigue.  Exhaled gases were analyzed during 
the testing period using a metabolic cart (Moxus Metabolic Systems, Pittsburgh, PA). 
Anaerobic Power Measurements 
 Anaerobic power was measured on a cycle ergometer (Monark Ergomedic, Vansbro, 
Sweden) using the Wingate testing protocol (48).  The protocol included a self-selected warm-up 
period during which the participants pedaled at a relaxed frequency against little or no resistance.  
The testing period required the subjects to pedal against a given resistance, calculated based on 
the body weight of the subject, for 30 seconds. This period was followed by a cool-down period 
that lasted as long as was deemed necessary.  Revolutions per 5 second intervals were counted 
and applied to the Wingate equations (48). 
Strength, Power and Flexibility Testing 
 Strength measurements were assessed by eight repetition maximums (8RM) for several 
lifts, including upright bench press, bicep curl, tricep pushdown, leg curl, leg extension and 
upright row.  For assessment of power, subjects were asked to perform vertical and horizontal 
jumps, with allowed countermovement before each jump.  The best of three jumps was recorded 
and used for data analysis.  Vertical jump height was determined as the difference between the 
height of outstretched hand at rest and the highest point the subject reached during the jump; 
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horizontal jump distance was determined by initial landing spot of the subjects’ heel on a marked 
tape measure (49).  Subjects’ flexibility was assessed by a sit-and-reach test (47).   
Statistical Analysis 
 Data were analyzed using SPSS (Version 19, IBM, Armonk, NY).  Descriptive statistics, 
including mean and standard error (SE), were calculated for all outcome variables.  A one-way, 
four-level ANOVA was used to compare the subjects by gender and vitamin D status, either 
above HIGH (>35 ng/mL) or below LOW (<35 ng/mL) the normal value for physically active 
individuals (50).  Student’s t-tests with a Bonferroni multiple comparison correction were used 
post hoc.   Pearson stepwise correlation analysis was used to determine relationships between all 
measurements.  Significance was set at p < 0.05.  All values presented are mean ± SE.   
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CHAPTER 4 – RESULTS 
Subjects were between the ages of 20 and 38 years old and mean anthropometric 
measurements are shown in Table 1.  Forty subjects were recruited into the study.  One female 
was excluded from all analyses due to failure to complete testing.  One male subject was 
excluded from 25OHD serum analysis, as his value was considered a statistical outlier.  Overall, 
males had significantly higher dietary intake of vitamin D; however, there were no other 
significant differences in descriptive measures aside from those expected based on variation of 
body size and composition between genders (Table 1).   
Vitamin D Status: Measures of Intake and Serum Content 
Twenty subjects (9 females, 11 males) presented with serum 25OHD levels lower than 35 
ng/mL, which is considered to be below normal in young, physically active individuals (50) 
(Table 2).  While the recommended daily intake of vitamin D is 600 IU (51), or 4200 IU per 
week, only one subject in the study met this criterion.  However, this subject’s serum 25OHD 
still fell below the normal 25OHD level. The mean dietary vitamin D intake for participants was 
just above 1000 IU per week, and these values did not correlate with serum levels (Figure 1).  
Intake was significantly higher in males than in females (p = 0.002); however, there was no 
significant difference in intake between the HIGH and LOW vitamin D groups (p = 0.93) nor 
was there a relationship between vitamin D intake and serum 25OHD content (r = 0.003). 
Sun Exposure 
Using the charting procedure for sun exposure, scores ranged from 11 to 52.  In the study 
in which the survey measurement was proposed, the scores ranged from 0 to 41 (43).  In 
addition, there were no significant differences in sun exposure between men and women, or the 
HIGH and LOW vitamin D groups (p = 0.66 and p = 0.81, respectively) (Table 2). There were 
 18 
no significant correlations in the complete data set, nor were there any correlations when divided 
by gender or between the high and low 25OHD groups. 
Body Composition and Resting Metabolic Rate 
 Aside from the expected differences in percent body fat between genders (P ≤ 0.001), 
there were no other significant differences in percent body fat between groups (Table 1)(52).  
There was a non-significant negative trend between vitamin D status and BMI (r = -0.31, p = 
0.19).  This relationship was also observed in body composition in males, showing decreased 
adiposity with increased serum 25OHD (r = -0.38, p = 0.20). As expected, there was a significant 
difference between RMR in men and women (P ≤ 0.001) (Table 2) but no significant difference 
in resting metabolic rate between the high vitamin D group and the low vitamin D group (p = 
0.94) was observed (Table 2)(53).  Of the subjects with normal serum 25OHD levels, there was a 
positive but non-significant correlation between resting metabolic rate and vitamin D status 
(males n = 9, r = 0.26 and females, r = 0.41). 
Performance Measurements 
There was a statistically significant difference in VO2max between males in the low and 
high groups (p ≤ 0.01), where males with serum vitamin D above the recommended levels for 
physically active adults had roughly a 20% higher VO2max compared to those who fell below the 
normal standard (Figure 1).  This relationship was not observed in females, and there were no 
other statistically significant differences in VO2max among any other groups (data not shown). 
Anaerobic power (P ≤ 0.001) was significantly higher in males than females; however, 
there were no significant differences in anaerobic power based on 25OHD status (p = 0.76 for 
females and p = 0.34 for males) (Table 2).  The lack of significance was maintained when 
comparing absolute measurements or watts per body weight (kg) between LOW and HIGH 
25OHD groups.  As expected, males had significantly higher 8RMs in all lifts compared to 
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females (P ≤ 0.001), as would be predicted (Table 2). However, there were no significant 
differences between LOW and HIGH groups in any of the 8RM or flexibility measurements 
(Table 2). 
Correlational Analysis 
 Correlations were performed between 25OHD concentrations and all outcome variables 
for the entire group of subjects, by gender, and by LOW and HIGH groups.  No statistically 
significant relationships were discovered. 
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CHAPTER 5 – DISCUSSION 
Based on the known and purported benefits of vitamin D, it is recommended that 
physically active individuals maintain a higher vitamin D status to achieve optimal health and 
performance benefits (12, 31).  In this study, we also show that males who had serum 25OHD 
levels above the recommended limit of 35 ng/mL had significantly higher cardiorespiratory 
fitness levels when compared to males below this value.  These findings are in agreement with 
the results of several studies investigating the relationships among serum 25OHD, 
cardiorespiratory fitness and several markers of mortality in middle-aged men and women (54, 
55). These markers included several indices of obesity, changes in insulin resistance and glucose 
metabolism, as well as decreases in inflammation and triglyceride content (56, 57).  While the 
evidence is conclusive that physical activity can induce all of these changes alone (58), it is 
possible that increasing 25OHD may also induce these beneficial effects may help clinical 
populations as well (57). 
In this study, there were no significant relationships between strength or power output 
and serum 25OHD, nor were there observed relationships between 25OHD and flexibility 
measures.  It has been shown that increasing serum 25OHD status in elderly populations results 
in improvements in muscle mass and strength, and that low levels of 25OHD accurately predict 
the acceleration in age-related loss of muscle mass (59, 60), which was not observed in the 
current study.  This finding may be a function of regular exercise modality.  For example, males 
were more inclined to engage in a structured routine with strict running distances and weight 
lifting protocols while females were more likely to engage in a variety of running distances and 
events or other aerobic group physical activity classes.  This gender-based variation in training 
regimen could potentially influence the development of muscle strength and power differently in 
each group, which would cause the observed differences between males and females in strength 
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and power.  There were no significant differences in flexibility when associated with 25OHD 
content.  There are no studies in young, healthy populations investigating this relationship. Only 
a few results in elderly populations show improvements in flexibility, which is due to the 
changes in muscle tissue that occur with increases in 25OHD content (61). 
Low levels of 25OHD are associated with high levels of body fat (9, 13).  In this study, 
there was a trend (p = 0.20) for a negative correlation between 25OHD and body fat percentage 
in males. Additionally, there was no relationship between 25OHD and RMR and a consensus on 
this relationship has not yet emerged in the literature.     
Half of the healthy, physically active participants in this study presented with insufficient 
or deficient levels of serum 25OHD.  Clinical studies have defined deficiency as serum levels 
below 10 ng/mL and insufficiency as levels between 10 and 30 ng/mL (62); however, depending 
on the research environment, these reference values may fall between 15 and 35 ng/mL.  
Because vitamin D studies have been conducted in a wide variety of populations, it cannot be 
assumed that the same reference values apply to all individuals (63).  We considered 35 ng/mL 
as the normal reference value for subjects in this study because this cutoff has been used as the 
reference value in a previous study with physically active individuals (32). 
 Studies have shown that it is difficult to achieve adequate vitamin D status using dietary 
measures alone, especially when considered independent of supplementation with multivitamins 
(42).  In the United States, many foods are required by the Food and Drug Administration to be 
fortified with vitamin D, including but not limited to: orange juice, dairy products and cereals 
(63).  While the fortification of these foods helps to increase vitamin D intake, they cannot be 
considered a means for obtaining sufficient vitamin D (42).  As a result, it is not surprising that 
the dietary intake of vitamin D was extremely low in the young adults enrolled in this study.  The 
Institute of Medicine’s recommendation for vitamin D is 600 IU per day, and only one of the 39 
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subjects in the current study met this requirement with an average daily intake of 700 IU (4,644 
IU per week).  This is a common trend and several recently published studies have reported 
similar results in young, physically active individuals (50, 64). 
Vitamin D levels (25OHD) are not only associated with dietary intake, but are also 
related to UV exposure (16).  Data were collected during the summer and early fall in the 
southeastern United States where the number of days with adequate UV exposure from sunlight 
is estimated at 218 per year.  Current recommendations suggest that ten to fifteen minutes in 
sunlight will produce a large amount of vitamin D, but this conversion is affected by a number of 
different factors, including ethnicity, adiposity, age, geographical location, as well as behaviors 
such as sunscreen use or wearing protective clothing (17, 65).  In this study, sun exposure was 
evaluated by a survey that allowed for direct combination of time spent in the sun as well as 
overall exposure (43).  We used this particular survey because many individuals in the current 
study enjoy recreational activities outdoors, but did so under different conditions including time 
of day or wearing various different types of clothing, making analysis of time under UV 
exposure difficult.  The scores obtained in the present study varied significantly as both a 
function of time spent outdoors and the amount of skin exposed to sun.  We found no correlation 
between sun exposure or dietary intake and serum 25OHD levels.  Surprisingly, we also found 
no significant relationship between length of sun exposure and serum 25OHD, despite that fact 
that most subjects reported infrequent sunscreen use, which maximized the potential for 
endogenous vitamin D production.  These results are confirmed in studies investigating the 
vitamin D status of different populations in the United States (66, 67).  Previous reports and the 
present results indicate that individuals with significant sun exposure may still be at risk for 
vitamin D deficiency. 
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One of the biggest challenges in vitamin D research is the understanding of optimal levels 
for different populations.  Because the benefits of increasing serum 25OHD in athletes are not 
completely elucidated to date, current research is beginning to determine the concentration at 
which optimal health and athletic performance occurs in physically active individuals.  Studies in 
adolescent dancers note that non-specific musculoskeletal pain occurred with serum 
concentrations as low as 20 ng/mL (68), with a decrease in athletic performance observed in a 
population where mean serum 25OHD concentration was 12 ng/mL (33).  It is also important to 
note that optimal concentrations for populations with chronic illness are thought to be 25 ng/mL, 
Accordingly, the estimate of  “normal” serum 25OHD concentration (> 35 ng/mL) used in the 
current study is a conservative for young, healthy, and physically individuals. 
 Our current study includes several limitations.  First, subjects were mostly Caucasian (n = 
36) with several Hispanics (n = 3) but included no African Americans.  The observed levels of 
insufficiency would have potentially been greater if more minorities had been recruited, as they 
are at a higher risk for insufficiency or deficiency because increased melanin plays a role in 
blocking the production and circulation of 25OHD (18).  It is crucial to point out that our data 
were analyzed using the USDA Nutrient Database for vitamin D content (44).  While the 
amounts listed in the USDA nutrient database include amounts of both D2 and D3, D3 is 
regarded to be much more biologically active in humans (19).  Therefore, the dietary analysis 
included the highest possible value because it considers both forms.  It should be noted that 
dietary intake was significantly higher in males than in females (n = 20 males, n = 19 females).  
This difference in dietary intake may be due to the fact that males tend to eat more on a daily 
basis (69). 
In conclusion, this study showed a positive relationship between aerobic fitness and 
25OHD status in physically active males. A secondary finding was that vitamin D intake was 
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lower than that which is currently recommended, and a large percentage of young, healthy and 
physically active individuals had low serum levels of 25OHD.  Finally, sun exposure and dietary 
intake did not appear to influence 25OHD status.     
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CHAPTER 6 – CONCLUSION 
 Results of this study are promising.  A significant percent of a young, active population 
presented with low levels of an important nutrient, therefore it is important to increase awareness 
of the importance of including vitamin D in an overall healthy diet..  It is documented in studies 
using subjects between ages ranging from adolescence to the community-dwelling elderly that 
insufficient levels of 25OHD are associated with symptoms such as muscle soreness and 
myopathy, even significant muscle weakness (5, 33).  In children and the elderly, the benefits of 
vitamin D are even more important, as bone growth and maintenance are tightly correlated with 
levels of 25OHD (70).  Since vitamin D is essential for bone health, as well as potentially 
increasing athletic performance and altering body composition, it is important for young 
individuals and athletes to appreciate its nutritive value (31).   
Because there was a significant difference between males above and below the normal 
serum 25OHD levels and the resulting levels of aerobic fitness, further research in the area of 
supplementation and resulting athletic performance is warranted.  There is very little 
understanding about the direction of this relationship at this time.  Some of the most recent 
studies showed a positive relationship between cardiorespiratory fitness, as measured by VO2max 
treadmill testing, and serum 25OHD levels (54, 55).  These results are noteworthy, as the 
relationship was observed in both healthy adult men and women, and was conducted using 
several thousand subjects.  The major disadvantage to these studies were the confounding factors 
of adiposity, as there was a negative relationship observed between both 25OHD and body fat, as 
well as cardiorespiratory fitness and obesity.  While the former would suggest that vitamin D 
status could positively influence body composition, the latter clouds the understanding of this 
relationship.  Many factors influence this relationship.  Individuals who are more aerobically fit 
tend to spend more time outdoors and consistently have diets higher in nutritious foods, most 
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definitely those that have increased vitamin D content (54).  The converse relationship is also 
true: those who are less fit tend to spend more time indoors and or have a diet high in processed 
foods, lacking basic nutrients.  Therefore, the directionality of the results observed in the 
mentioned studies cannot be determined.  Further work in understanding this relationship should 
be conducted using a longitudinal training study, in which subjects are supplementing and 
participating in a concurrent athletic training program.  Resulting changes in fitness and body 
composition could be compared to subjects who are given a placebo but still participating in 
physical activity.  In fact, this is the next step in the research plan, which began with the present 
study.   
Future Directions 
 Improvements in body composition and fitness levels are understood on many 
physiological levels, but the resulting reduction in chronic levels of inflammation is perhaps the 
most positive systemic change.  It is understood that an increase in adiposity results in an 
increase in low-grade inflammation (71).  The effects of this rise in inflammation include 
impaired glucose and lipid metabolism, increased insulin resistance, or vascular destruction, 
which can lead to a cardiovascular event (71).  However, all of these adverse effects can be 
overcome in part with exercise training (72).  While the concentration of inflammatory cytokines 
increases acutely with exercise, chronic training leads to an increased ability to attenuate overall 
inflammation by both a decrease in proinflammatory cytokines and increase in anti-inflammatory 
cytokines (72).  One of the secondary investigations concerning 25OHD is its role in improving 
immune function (31, 64).  New studies using cell culture models have indicated that 25OHD 
directly inhibits the production of inflammatory cytokines IL-6 and TNF-α (73).  Further 
analysis indicated that this inhibition was due to binding of 25OHD to DNA, causing activation 
of a gene that produces MKP-1 (73).  MKP-1 interferes directly with the cellular pathway 
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leading to the production of IL-6 and TNF-α (73).  These results are novel and directly 
applicable to clinical populations, indicating the importance of maintaining high 25OHD levels 
in those suffering from obesity, type 2 diabetes, or other chronic conditions.  A major topic of 
interest would be the changes in inflammation that occur in the presence of increased 25OHD 
concentrations in those who are physically active.  This topic is of considerable interest to those 
who conducted the present study and is a potential future step in their line of research. 
In summary, increasing vitamin D levels has the potential to increase muscle mass and 
decrease adiposity, which can potentially regulate systemic inflammation.  Future research 
should focus on understanding these and other physiological changes that are caused by vitamin 
D.  Additionally, because of the large percentage of individuals with insufficient levels of 
25OHD, other investigations should focus on ways to effectively measure vitamin D status and 
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Table 1. Demographic and Anthropometric Measures 
  Gender 25OHD Status 
 Overall Male Female Low High 
Number of Participants 39 20 19 20 19 
Males (n) 20   11 9 
Females (n) 19   9 10 
Age   23.26 ± 0.7   23.75 ± 1.1   22.74 ± 0.7   22.75 ± 0.5   23.79 ± 1.2 
Height (cm) 167.77 ± 1.9 174.37 ± 2.1 160.82 ± 2.3 169.29 ± 2.5 166.17 ± 2.9 
Weight (kg)   68.85 ± 2.1   77.29 ± 2.4   59.79 ± 1.8   71.96 ± 3.1   65.40 ± 2.6 
% Body Fat   24.19 ± 1.3   18.65 ± 1.5   30.02 ± 1.0   24.66 ± 1.7   23.69 ± 2.0 
BMI   24.34 ± 0.6   25.45 ± 0.8   23.17 ± 0.7   24.99 ± 0.9   23.65 ± 0.7 
 
Data are presented as means ± SE.  BMI, body mass index; RMR, resting metabolic rate; 25OHD, 25-hydroxyvitamin D. 
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Table 2. Performance Measures Outcomes 
  Gender 25OHD Status 
 Overall Male Female Low High 
Number of Participants 40 20 19 20 19 
Males (n)    11 9 
Females (n)    9 10 
RMR (kcal/day)  1435.38 ± 44.8   1593.78 ± 53.7 1268.64 ± 49.6 1438.32 ± 71.7 1432.28 ± 54.4 
25OHD (ng/mL)   34.83 ± 1.9   33.02 ± 2.1  36.73 ± 3.2  25.97 ± 1.2   44.15 ± 2.2* 
Dietary Intake (IU/week) 1117.16 ± 169.2   1601.90 ± 273.6
†
   606.90 ± 112.4 1131.55 ± 254.1 1102.00 ± 228.6 
Sun Exposure (score)  28.82 ± 1.8  29.60 ± 2.9  30.02 ± 1.0  28.40 ± 2.7  29.26 ± 2.3 
Anaerobic Power (watts)  634.45 ± 28.2  753.43 ± 31.5
†
  509.21 ± 25.3  662.41 ± 40.5  605.02 ± 39.1 
Bench Press (kg)  68.28 ± 5.1  93.18 ± 5.3
†
  42.06 ± 2.6  73.44 ± 7.9  62.84 ± 6.4 
Leg Curl (kg)  41.04 ± 2.4 51.98 ± 2.5
†
  29.51 ± 1.9  42.56 ± 3.7  39.43 ± 3.0 
Leg Extension (kg)  55.76 ± 3.8 72.87 ± 4.1
†
  37.75 ± 2.7  58.11 ± 5.5  53.29 ± 5.2 
Upright Row (kg)  54.01 ± 3.3 69.92 ± 3.2
†
  37.28 ± 2.1  56.52 ± 5.0  51.37 ± 4.2 
Bicep Curl (kg)  27.24 ± 2.5 38.36 ± 2.6
†
  15.53 ± 1.9  29.40 ± 3.9  24.97 ± 3.0 
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 Data are presented as means ± SE. * Indicates significant difference between high and low status (p < 0.05); 
†
 Indicates significant 
difference between males and females (p < 0.05). 
Tricep Pushdown (kg)     62.40 ± 4.4   81.95 ± 4.8
†
    41.82 ± 3.5   65.60 ± 6.8    59.02 ± 5.6 
Vertical Jump (cm)     47.28 ± 1.7   54.36 ± 2.1
†
    39.84 ± 1.2   48.13 ± 2.3    46.39 ± 2.6 
Horizontal Jump (cm)   193.50 ± 5.6 219.33 ± 5.9
†
  166.30 ± 4.0 195.58 ± 7.6  191.30 ± 8.3 
Sit and Reach (cm)     11.20 ± 2.0     6.35 ± 3.0
†
    16.31 ± 2.2     7.75 ± 3.0    14.84 ± 2.6 
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Table 3. Data by 25OHD Status and Gender 
 
 Females Males 
 LOW HIGH LOW HIGH 
Number of Participants 9 10 11 9 
Age 23.56 ± 1.0     22.00 ± 0.8 22.09 ± 0.5     25.70 ± 2.3 
Height (cm)   162.00 ± 2.4
†
   159.77 ± 3.8
†
   175.26 ± 3.0   173.28 ± 3.0 
Weight (kg)     61.34 ± 3.6
†
     58.29 ± 1.4
†
     80.54 ± 3.0     73.18 ± 3.76 
% BF     29.81 ± 1.2
†
     30.20 ± 1.5     20.45 ± 2.3     16.46 ± 1.9 
BMI     23.27 ± 1.0     23.08 ± 1.0
†
     26.40 ± 1.2     24.30 ± .89 
RMR (kcal/day) 1266.00 ± 96.2
†
 1271.01 ± 44.0
†
 1579.32 ± 85.4 1611.46 ± 63.4 
25OHD (ng/mL)     26.04 ± 1.9
†
     46.34 ± 3.8*
†
     25.92 ± 1.6     41.71 ± 1.6* 
Dietary Intake (IU/week)   686.00 ± 202.8
†
     535.7 ± 117.9
†
 1181.30 ± 287.3 1731.22 ± 369.8 
Sun Exposure (score)     29.33 ± 3.6
†
       26.8 ± 2.3
†
     27.64 ± 4.0     32.00 ± 4.2 
VO2max (mL/kg/min)     45.98 ± 1.7
†
     45.02 ± 2.4
†
     49.66 ± 1.96     59.21 ± 2.9* 
Anaerobic Power (watts)   517.35 ± 38.1
†
   501.88 ± 35.4
†
   781.09 ± 39.6   719.62 ± 50.9 
Bench Press (kg)     43.34 ± 5.2
†
     40.82 ± 1.8
†
     97.94 ± 7.9     87.19 ± 6.8 
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Table 3 – continued 
 
Leg Curl (kg)     28.98 ± 3.4
†
     29.94 ± 2.1
†
     53.61 ± 3.7     49.90 ± 3.2 
Leg Extension (kg)     39.31 ± 5.5
†
    36.29 ± 1.9
†
     73.40 ± 5.8     72.07 ± 6.1 
Upright Row (kg)     38.81 ± 4.1
†
    35.83 ± 1.6
†
     70.93 ± 5.3     68.54 ± 3.2 
Bicep Curl (kg)     16.38 ± 3.9
†
    14.74 ± 1.4
†
     40.00 ± 4.1     36.29 ± 3.2 
Tricep Pushdown (kg)     44.86 ± 7.4
†
    39.01 ± 1.21
†
     82.47 ± 7.6     81.14 ± 5.6 
Vertical Jump (cm)     39.79 ± 1.5
†
    39.88 ± 1.9
†
     54.96 ± 2.4     53.62 ± 3.8 
Horizontal Jump (cm)   169.05 ± 4.8
†
  163.83 ± 6.4
†
   217.29 ± 9.0   221.83 ± 7.5 
Sit and Reach (cm)     11.85 ± 3.8
†
    20.32 ± 1.8
†
       4.49 ± 4.4       8.75 ± 4.0 
 
Data are presented as means ± SE.  * Indicates significant difference between comparison groups of the same gender (p < 0.05).  
†
 
Indicates significant difference between females and both HIGH and LOW males (p < 0.05).
 42 
Figure 1. 
Data represent maximal cardiorespiratory fitness (VO2max ml/kg/min) expressed as mean (SE) for males and females above (HIGH) or 
below (LOW) a normal standard level of serum 25OHD (35 ng/mL). * Indicates that HIGH male subjects are significantly higher than 
their LOW counterparts.  
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Figure 2. 
Weekly dietary intake of vitamin D among subjects (n = 38, outlier excluded) are presented as international units per week.  Solid line 
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